Drug News
-
AvKARE, LLC. Issues Voluntary Nationwide Recall of Atovaquone Oral Suspension Due to Potential Contamination: What Consumers Need to Know
AvKARE, LLC has initiated a voluntary recall of Atovaquone Oral Suspension, USP 750 mg/5 mL, lot # AW0221A, due to…
Read More » -
Revived Patent Challenge: Teva and Viatris Poised to Shake Up Schizophrenia Drug Market
In a recent development, Teva Pharmaceutical Industries Ltd and Viatris Inc have successfully persuaded a U.S. appeals court to revive…
Read More » -
Revolutionizing Healthcare Awareness Through Educational Innovation
Picture Credit In an age where information matters, how we impart knowledge is crucial. There has been a significant transformation…
Read More » -
Kobayashi Pharmaceutical To Withdraw Red Yeast Rice Capsules From The Market After 2 Two Fatalities
The Japanese health authorities have taken swift action by ordering Kobayashi Pharmaceutical (4967.T) to recall three dietary supplement products containing…
Read More » -
U.S. FDA Approves Akebia’s Vadadustat For CKD-induced Anemia
On March 27, the U.S. Food and Drug Administration (FDA) granted approval to Akebia Therapeutics’ (AKBA.O) drug, vadadustat, for the…
Read More » -
US FDA Approves Merck’s Winrevair for Rare Lung Condition
The U.S. Food and Drug Administration’s recent approval of Merck’s (MRK.N) treatment for adults suffering from high blood pressure due…
Read More » -
Alternative Medicine Modalities for Primary Health Care: A Primer
In recent years, there has been growing interest in alternative medicine modalities as complementary options to conventional primary health care.…
Read More » -
US Impose Fentanyl-related Sanctions on Sinaloa Members, Mexico-based Entities
The United States’ decision to impose sanctions on 15 Sinaloa Cartel members and six Mexico-based entities marks a significant escalation…
Read More » -
How Safety Innovations are Transforming Healthcare
In the quickly evolving landscape of healthcare, safety innovations stand at the very front of transforming patient care and functional…
Read More » -
Testosterone Replacement Therapy Market to Reach $2.9 Billion Globally, By 2032
The Testosterone Replacement Therapy (TRT) market is poised for significant growth, with a projected global value of $2.9 billion by…
Read More »